That was the moment in 2004 when we knew why we would serve.   Jody L. Taualofai, RN, pointed to a patient's graph that clearly showed we were able to detect respiratory infections before symptoms.   To prove their discovery, Jody and John Beiswenger traveled together to China shortly after the SARS epidemic to set up pre-clinical trials of the technology.

◄ Actual graph in the discovery

Biosymtec Medical

The Biosymtec Medical story actually began here at a company managed by John, now Biosymtec Medical's current CTO. It was here they gained substantial background in monitoring and graphing the health of chronically ill people.   It is also where John received experience in monitoring the reproductive cycles of over 400 infertility patients, adding to his experience researching infertility with the University of Illinois College of Medicine and the Medical College of Wisconsin, years earlier.

This Graph developed for infertile couples became valuable to physicians monitoring their patients remotely for respiratory or non-respiratory infections and changes in their pulmonary function. These are the patients with COPD, asthma and CHF, now representing Biosymtec Medical's primary markets.

◄ Infertility patient's graph

To conveniently and quickly acquire the data for these graphs, a new product was conceived, the Biosymtec Monitor.   Biosymtec Monitors will include Bluetooth® components which permit the transmission of collected data to subscribing patient smartphones and on to the Biosymtec System where the data can be stored, graphed, and made available to subscribing physicians within seconds anywhere in the world.

This will enhance patient/doctor relationships when remote monitoring is necessary or beneficial, another reason why we serve.

We believe Biosymtec Medical's products will save the lives of many patients and their caretakers. They will help to keep chronically ill patients out of the hospital, being treated instead by their physicians in their clinics.   We also believe Biosymtec Medical products will help those with COPD, Asthma, CHF and, yes, with Cystic Fibrosis live longer and healthy lives.   This too is Why We Serve.

The Biosymtec Medical Management Team


Thomas W. French, Jr.
President and CEO

Tom French possesses a 30-year professional track record creating shareholder value start-ups and turn-arounds.   His holistic approach to improving business performance by seamlessly integrating market strategy with operations, sales, marketing and customer service while creating high-functioning teams establishes a platform for growth.   Tom led a marketing-driven, turn-around of the largest US cable company precipitating a $48B sale to AT&T.   He turned-around an innovative biotech company, secured EPA and FDA approval of technology, built a 20-item line of consumer and commercial products, achieved nation-wide distribution with #1 Pharmacy retailer and raised $4.5M to expand operations and enter new markets for this technology.


John L. Beiswenger
Chairman and CTO

John Beiswenger has 50 years of product research, design engineering, product development, manufacturing, product management, general management, marketing and sales experience in high volume consumer and commercial hard goods.   This includes 20 years in health monitoring technology.   He has placed over 65 products into production, monitoring pilot production in the U.S., Ireland, France, Japan, Taiwan, Hong Kong, and Mainland China.   Beiswenger is named on over 30 U.S. and foreign utility patents, the most recent including color LCD touch display technology, digital alarm clock electronics, fingerprint scanning technology, surgical instrument sterilization, bioterrorism detection, and predictive health monitoring technology.

The Biosymtec Medical Advisory Board

James A. Wilson
MD
COVID Report

Daniel J. Beiswenger
Design Coordinator

Joseph E. Johnson Jr. III
Biochemist

© 2020  Biosymtec Medical, Inc.